Released Oct 27, 2016, after the close
10-Q filed Oct 28, 2016, 28 days after period end · 0000917520-16-000100
Q3 2016 · 10-Q
Revenue$250.33M$250.33M +10.6% vs Q3 2015+0.4% vs Q2 2016
Net Income$20.14M$20.14M N/M vs Q3 2015+57.9% vs Q2 2016
EPS Diluted$0.25$0.25 N/M vs Q3 2015+56.3% vs Q2 2016
Gross Profit$161,003,000+14.8%
Operating Income$30,095,000+201.1%
Operating Cash Flowderived$46,767,000+138.5%
Free Cash Flowderived$39,793,000+179.2%
Margins · derived
Gross margin64.3%+2.3 pt vs Q3 2015
Operating margin12.0%+7.6 pt vs Q3 2015
Net margin8.0%+22.1 pt vs Q3 2015
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Revenue | $250.33M | $226.37M | $197.52M | $213.25M |
| Net Income | $20.14M | -$31.88M | $9.81M | -$30.33M |
| EPS Diluted | $0.25 | -$0.45 | $0.30 | -$1.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR